ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 45 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $404,000 | – | 544,351 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 8,343,716 | $2,053,000 | 2.58% |
| Sio Capital Management, LLC | 4,935,250 | $1,214,000 | 0.29% |
| Endurant Capital Management LP | 2,481,355 | $610,000 | 0.24% |
| Fosun International Ltd | 596,752 | $147,000 | 0.01% |
| Malaga Cove Capital, LLC | 30,000 | $7,000 | 0.01% |
| Summit X, LLC | 35,000 | $8,000 | 0.00% |
| ARDSLEY ADVISORY PARTNERS LP | 75,000 | $19,000 | 0.00% |
| Fosun International Ltd | 168,851 | $42,000 | 0.00% |
| INTRUST BANK NA | 40,000 | $10,000 | 0.00% |
| Cetera Advisor Networks LLC | 142,500 | $49,000 | 0.00% |